Public Health - Opioid Overdose Reversal Drugs

HB 572 requires health care providers issuing standing orders for opioid overdose reversal drugs to let patients choose any FDA-approved type of these drugs. It directly affects patients at risk of opioid overdose and the health care providers, clinics, or community organizations that prescribe or dispense these drugs. The bill prohibits entities from being forced to stock or dispense all FDA-approved reversal drug types, instead allowing them to offer available options. This law amends Maryland's health code to clarify patient choice and reduce administrative burdens on providers.